Drägerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA (DRWKF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
drwkf · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Drägerwerk AG & Co. KGaA (DRWKF) measures how much investors pay for each dollar of the company's trailing earnings. DRWKF's current PE ratio of 10.83x is calculated by dividing its stock price of $111.58 by its TTM earnings per share of $8.16. +49.3% elevated vs 5Y avg 7.3x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 19 fiscal years · Front-end computedMinQ1 · 25%12.6x
MedianQ3 · 75%51.4x
Max
At 10.83x, DRWKF's current P/E is within its average historical range over the past 19 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Drägerwerk AG & Co. KGaAYou DRWKF | $2.1B | 10.83x | -65.4% | $8.16 |
 AS ONE Corporation IUSDF | $998M | 17.20x | -45.0% | $129.15 |
 Medacta Group S.A. MEDGF | $1.7B | 14.86x | -52.4% | $4.80 |
 Nippon Shinyaku Co., Ltd. NPNKF | $2.2B | 11.44x | -63.4% | $444.03 |
 Neuren Pharmaceuticals Limited NURPF | $1.2B | 81.52x | +160.8% | $0.24 |
 Redcare Pharmacy N.V. SAEYY | $1.1B | N/A | — | -$0.18 |
 Redcare Pharmacy N.V. SHPPF | $1.1B | N/A | — | -$1.87 |
Industry Average 4 peers with valid PE | — | 31.26x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 9.26x | $7.44 | +35.0% | |
2024-12-31 FY2024 | 6.86x | $6.63 | -6.3% | |
2023-12-31 FY2023 | 7.32x | $5.89 | — | |
2022-12-31 FY2022 | — | $-3.44 | — | |
2021-12-31 FY2021 | 6.39x | $8.22 | -0.4% | |
2020-12-31 FY2020 | 6.42x | $10.22 | -77.6% | |
2019-12-31 FY2019 | 28.68x | $1.88 | +13.5% | |
2018-12-31 FY2018 | 25.26x | $1.93 | +100.9% | |
2017-12-31 FY2017 | 12.58x | $5.54 | -41.4% | |
2016-12-31 FY2016 | 21.47x | $4.62 | -58.2% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Drägerwerk AG & Co. KGaA (DRWKF) measures how much investors pay for each dollar of the company's trailing earnings. DRWKF's current PE ratio of 10.83x is calculated by dividing its stock price of $111.58 by its TTM earnings per share of $8.16.
Frequently asked questions
DRWKF pe ratio · 6 questionsDRWKF's current PE ratio is 10.83x as of 2026-06-09, based on a stock price of $111.58 and TTM EPS of $8.16. Data sourced from Financial Modeling Prep via DRWKF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Drägerwerk AG & Co. KGaA SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09